Ancient gold remedy put to the test for Children's immune health
NCT ID NCT07724561
First seen Jul 24, 2026 · Last updated Jul 28, 2026 · Updated 2 times
Summary
This pilot study in Nepal is testing whether suvarnaprashana — a traditional Ayurvedic preparation made with purified gold, honey, and ghee — is safe and may strengthen the immune system in healthy children aged 2 to 5 years. Over 8 weeks, researchers will monitor for side effects and measure changes in immune markers like antibody levels and T-cell counts. The goal is to gather early evidence that could justify larger trials and potentially offer a simple way to help children fight off common infections.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- an Ayurvedic gold-based formulation (suvarnaprashana) containing purified gold, honey, and clarified butter (ghee), taken orally once daily for 30 days
- What this could lead to
- If safe and effective, this traditional remedy could offer a simple way to support children's immune health and reduce common infections.
- What could go wrong
- This is a very small pilot study (40 children) with no blinding, so results may not be reliable. Gold-based products also carry unknown risks in young children.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 40 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
2 to 5 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Healthy children aged 2-5 years * WHO Z-score between -2 and +2 standard deviations * Normal complete blood count (CBC), liver function test (LFT), and renal function test (RFT) * Written informed consent from parent or guardian * Ability to adhere to study protocol Exclusion Criteria: * Immunodeficiency (congenital or acquired) * Known hypersensitivity to gold, honey, or ghee * History of severe allergic reactions * Presence of any chronic illness or acute infection at screening
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy children are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A pharmacokinetic study of NTI164 in healthy adult volunteers
- Can a new injection SGB-9768 pass its first safety test?
- Can a new PET tracer reveal the Body's hidden stress?
- A daily yogurt drink might strengthen your immune defenses
- Zapping the brain to shift Decision-Making in depression and aging
- Can a new formula make omega-3 and vitamin D3 supplements work better?